DHJJ Financial Advisors’s AbbVie ABBV Stock Holding History

DHJJ Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$412K	Buy	1,638 +3	+0.2%	+$645	0.12%	131
2026 Q1	$356K	Buy	1,635 +80	+5%	+$17.7K	0.12%	139
2025 Q4	$355K	Buy	1,555 +2	+0.1%	+$456	0.12%	135
2025 Q3	$360K	Sell	1,553 -13	-0.8%	-$2.65K	0.12%	126
2025 Q2	$291K	Buy	1,566 +3	+0.2%	+$558	0.1%	139
2025 Q1	$327K	Buy	1,563 +86	+6%	+$16.7K	0.13%	121
2024 Q4	$262K	Hold	1,477	–	–	0.1%	138
2024 Q3	$292K	Hold	1,477	–	–	0.12%	125
2024 Q2	$253K	Hold	1,477	–	–	0.11%	134
2024 Q1	$269K	Hold	1,477	–	–	0.12%	119
2023 Q4	$229K	Hold	1,477	–	–	0.11%	129
2023 Q3	$220K	Buy	+1,477	New	+$217K	0.11%	126
2023 Q2	–	Sell	-1,476	Closed	-$235K	–	135
2023 Q1	$235K	Hold	1,476	–	–	0.13%	126
2022 Q4	$239K	Buy	+1,476	New	+$226K	0.14%	123
2022 Q3	–	Sell	-1,476	Closed	-$226K	–	129
2022 Q2	$226K	Hold	1,476	–	–	0.13%	122
2022 Q1	$240K	Buy	+1,476	New	+$214K	0.12%	123

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DHJJ Financial Advisors's ABBV Position: Q2 2026 in Review

DHJJ Financial Advisors increased its AbbVie (ABBV) stake by 0.18% in Q2 2026, buying an estimated $645 and bringing the position to 1,638 shares worth $412K. The position accounts for 0.12% of the portfolio, ranked #131.

DHJJ Financial Advisors first reported a position in ABBV in Q1 2022 and has held it in 16 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

DHJJ Financial Advisors held 1,638 shares of AbbVie worth $412K as of Q2 2026.
DHJJ Financial Advisors bought 3 AbbVie shares in Q2 2026, an estimated $645.
AbbVie made up 0.12% of DHJJ Financial Advisors's portfolio in Q2 2026, its #131 holding.
DHJJ Financial Advisors first reported a position in AbbVie in Q1 2022 and has held it in 16 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on DHJJ Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.